Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4483698
Max Phase: Preclinical
Molecular Formula: C22H35N5O4
Molecular Weight: 433.55
Molecule Type: Unknown
Associated Items:
ID: ALA4483698
Max Phase: Preclinical
Molecular Formula: C22H35N5O4
Molecular Weight: 433.55
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC[C@H](C)[C@@H](CCC(=O)Nc1cncc(C(=O)O)c1N)NC(=O)[C@@H](N)C1CCCCC1
Standard InChI: InChI=1S/C22H35N5O4/c1-3-13(2)16(27-21(29)19(23)14-7-5-4-6-8-14)9-10-18(28)26-17-12-25-11-15(20(17)24)22(30)31/h11-14,16,19H,3-10,23H2,1-2H3,(H2,24,25)(H,26,28)(H,27,29)(H,30,31)/t13-,16+,19-/m0/s1
Standard InChI Key: KMNIDDYEAAZMNW-CRFBAAHOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 433.55 | Molecular Weight (Monoisotopic): 433.2689 | AlogP: 2.52 | #Rotatable Bonds: 10 |
Polar Surface Area: 160.43 | Molecular Species: ZWITTERION | HBA: 6 | HBD: 5 |
#RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 3.66 | CX Basic pKa: 9.33 | CX LogP: 0.55 | CX LogD: -0.25 |
Aromatic Rings: 1 | Heavy Atoms: 31 | QED Weighted: 0.38 | Np Likeness Score: -0.08 |
1. Yamada K, Nakazawa M, Matsumoto K, Tagami U, Hirokawa T, Homma K, Mori S, Matsumoto R, Saikawa W, Kitajima S.. (2019) Unnatural Tripeptides as Potent Positive Allosteric Modulators of T1R2/T1R3., 10 (5): [PMID:31098002] [10.1021/acsmedchemlett.9b00051] |
Source(1):